A detailed history of Gsa Capital Partners LLP transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 149,129 shares of TMCI stock, worth $1.14 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
149,129
Previous 191,427 22.1%
Holding current value
$1.14 Million
Previous $1.27 Million 32.05%
% of portfolio
0.07%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$5.01 - $8.45 $211,912 - $357,418
-42,298 Reduced 22.1%
149,129 $865,000
Q2 2024

Aug 15, 2024

BUY
$4.17 - $12.62 $509,382 - $1.54 Million
122,154 Added 176.34%
191,427 $1.27 Million
Q1 2024

May 03, 2024

SELL
$11.48 - $15.86 $106,970 - $147,783
-9,318 Reduced 11.86%
69,273 $904,000
Q4 2023

Feb 16, 2024

BUY
$6.03 - $12.88 $473,903 - $1.01 Million
78,591 New
78,591 $1 Million

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $423M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.